SK Pharmteco announced that it expanded its small molecule and peptide production capabilities with a $260 million investment. The Rancho Cordova, California-based CDMO plans to construct a new state-of-the-art facility in Sejong, South Korea. It expects to begin operations at the new plant — the company’s fifth in South Korea — in late 2026. The…

Eli Lilly (NYSE:LLY) announced today that it made a $4.5 billion investment to create the Lilly Medicine Foundry in Indiana. The new center offers capabilities for advanced manufacturing and drug development. Lilly expects to gain new ways to produce medicines while also scaling up manufacturing of medicines for clinical trials. Its first-of-its-kind facility combines research…

PCI Pharma Services announced that it’s investing more than $365 million in infrastructure to support assembly and packaging efforts. The investment supports the clinical- and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis on injectable formats. PCI Pharma plans to put its investment toward new and…

Curium announced today that it opened a new facility in Petten, The Netherlands, to produce non-carrier added lutetium-177 (Lu-177). The Paris-based company expanded its capacity to meet the growing global demand for Lu-177 for the treatment of cancer patients. Using in-licensed technology from Turkey-based Eczacıbaşı-Monrol, the facility will initially include two production lines. Curium also…

Wheeler Bio announced today that it expanded its capabilities through the licensing of ATUM’s miFuc platform. ATUM designed miFuc for the expression of recombinant proteins containing afucosylated glycans. The technology supports the development of antibodies with a significant reduction in fucosylation without affecting product titer, cellular growth rates or incurring global glycan liabilities. ATUM’s proprietary…

BD (NYSE:BDX) announced today that it launched its Neopak XtraFlow glass prefillable syringe and expanded capacity for the platform. The company said the launch and expansion aim to serve the growing market for biologic therapies. Neopak glass prefillable syringes address key development needs for biologic drugs, BD said in a news release. The syringes have…

Eli Lilly and Co. recently announced that it’s spending $1 billion to expand its Limerick, Ireland, manufacturing site. The goal of the expansion, announced Sept. 12, is to increase the production of biologic active ingredients, including those for the company’s recently approved treatment for early symptomatic Alzheimer’s disease. The company announced in July that the…

Cellevate announced today that it closed a second seed round worth approximately $3.6 million to support its biomanufacturing technology. Industrifonden led the round in syndication with the European Innovation Council Fund (EIC Fund). The funding, combined with the first seed round last October, brings the company’s total funding to approximately 7.3 million. Lund, Sweden-based Cellevate…

Sanofi announced today that it’s shipping Beyfortus injection doses to the U.S. to ensure availability ahead of respiratory syncytial virus (RSV) season. The company shipped 50mg and 100mg injection doses of Beyfortus (nirsevimab-alip) to private healthcare providers and the Centers for Disease Control and Prevention for its Vaccines for Children program. Sanofi expects the U.S.…

The API Innovation Center (APIIC) announced that it received $14 million in U.S. government funding to lead a pharmaceutical production project. The Administration for Strategic Preparedness and Response’s (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC) provided the funding for APIIC to lead the development and domestic production of three critical active pharmaceutical…